OLIO Financial Planning Buys New Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

OLIO Financial Planning purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 1,175 shares of the medical equipment provider's stock, valued at approximately $582,000.

Several other institutional investors also recently added to or reduced their stakes in the company. Sycomore Asset Management increased its holdings in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider's stock valued at $9,214,000 after purchasing an additional 4,079 shares during the period. Castleark Management LLC increased its holdings in shares of Intuitive Surgical by 3.4% in the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after purchasing an additional 2,990 shares during the period. Truist Financial Corp increased its holdings in shares of Intuitive Surgical by 3.0% in the fourth quarter. Truist Financial Corp now owns 248,092 shares of the medical equipment provider's stock valued at $129,494,000 after purchasing an additional 7,298 shares during the period. Global X Japan Co. Ltd. increased its holdings in shares of Intuitive Surgical by 9.8% in the fourth quarter. Global X Japan Co. Ltd. now owns 46,289 shares of the medical equipment provider's stock valued at $24,161,000 after purchasing an additional 4,140 shares during the period. Finally, Northeast Investment Management boosted its stake in shares of Intuitive Surgical by 3.1% in the fourth quarter. Northeast Investment Management now owns 89,170 shares of the medical equipment provider's stock valued at $46,543,000 after buying an additional 2,685 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares of the company's stock, valued at $2,607,925.28. This trade represents a 68.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the transaction, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. This represents a 60.72% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 25,443 shares of company stock worth $12,692,195 in the last three months. 0.70% of the stock is owned by insiders.

Intuitive Surgical Trading Down 0.2%

NASDAQ:ISRG traded down $0.98 on Friday, hitting $557.08. 1,103,774 shares of the stock were exchanged, compared to its average volume of 1,641,815. The stock has a market cap of $199.67 billion, a PE ratio of 86.91, a PEG ratio of 5.85 and a beta of 1.67. The stock has a fifty day moving average of $521.99 and a 200-day moving average of $539.26. Intuitive Surgical, Inc. has a fifty-two week low of $413.52 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same period in the previous year, the company posted $1.50 EPS. As a group, analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts recently weighed in on the company. Barclays decreased their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Piper Sandler lowered their target price on shares of Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. Royal Bank of Canada lowered their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Finally, Robert W. Baird reduced their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $596.05.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.